All 3,418 procedure codes billed by Medicaid providers in Maryland, ranked by total spending.
| # | Code | Description | Total Paid |
|---|---|---|---|
| 1 | H0044 | Supported housing, per month | $1.66B |
| 2 | 90834 | Psychotherapy, 45 minutes with patient | $1.31B |
| 3 | 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | $1.14B |
| 4 | 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | $967.78M |
| 5 | S5102 | Day care services, adult; per diem | $753.14M |
| 6 | T1003 | Lpn/lvn services, up to 15 minutes | $692.80M |
| 7 | H0015 | Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education | $584.41M |
| 8 | H2016 | Comprehensive community support services, per diem | $579.69M |
| 9 | H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | $518.66M |
| 10 | T2022 | Case management, per month | $367.67M |
| 11 | Q5003 | Hospice care provided in nursing long term care facility (ltc) or non-skilled nursing facility (nf) | $325.55M |
| 12 | T2016 | Habilitation, residential, waiver; per diem | $284.04M |
| 13 | H2036 | Alcohol and/or other drug treatment program, per diem | $268.82M |
| 14 | H0040 | Assertive community treatment program, per diem | $261.37M |
| 15 | T1015 | Clinic visit/encounter, all-inclusive | $237.13M |
| 16 | W7350 | $235.02M | |
| 17 | W5102 | $202.06M | |
| 18 | 90847 | Family psychotherapy with the patient present, 50 minutes | $177.47M |
| 19 | 99284 | Emergency department visit for the evaluation and management, high severity | $176.90M |
| 20 | H0004 | Behavioral health counseling and therapy, per 15 minutes | $175.04M |
| 21 | W7370 | $166.60M | |
| 22 | T1023 | Screening to determine the appropriateness of consideration of an individual for participation in a specified program, project or treatment protocol, per encounter | $159.18M |
| 23 | 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | $141.02M |
| 24 | 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | $136.59M |
| 25 | 90837 | Psychotherapy, 53 minutes with patient | $132.00M |
| 26 | S9083 | Global fee urgent care centers | $128.31M |
| 27 | D1120 | Prophylaxis - child | $115.12M |
| 28 | D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | $114.73M |
| 29 | 90791 | Psychiatric diagnostic evaluation | $110.85M |
| 30 | W7330 | $109.76M | |
| 31 | 90832 | Psychotherapy, 30 minutes with patient | $108.86M |
| 32 | 81416 | $105.77M | |
| 33 | 97530 | Therapeutic activities, direct patient contact, each 15 minutes | $105.67M |
| 34 | H0005 | Alcohol and/or drug services; group counseling by a clinician | $101.55M |
| 35 | 99215 | Prolong outpt/office vis | $96.29M |
| 36 | D0120 | Periodic oral evaluation - established patient | $93.33M |
| 37 | W7375 | $90.00M | |
| 38 | T1019 | Personal care services, per 15 minutes, not for an inpatient or resident of a hospital, nursing facility, icf/mr or imd, part of the individualized plan of treatment (code may not be used to identify services provided by home health aide or certified nurse assistant) | $89.79M |
| 39 | A0427 | Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) | $87.06M |
| 40 | 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | $84.30M |
| 41 | 99232 | Subsequent hospital care, per day, moderate complexity | $79.23M |
| 42 | 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | $78.18M |
| 43 | 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | $74.59M |
| 44 | 99509 | Home visit for assistance with activities of daily living and personal care | $70.98M |
| 45 | D1206 | Topical application of fluoride varnish | $69.63M |
| 46 | D1351 | Sealant - per tooth | $68.31M |
| 47 | D1110 | Prophylaxis - adult | $67.93M |
| 48 | T1017 | Targeted case management, each 15 minutes | $67.41M |
| 49 | D0999 | Unspecified diagnostic procedure, by report | $65.93M |
| 50 | 99233 | Prolong inpt eval add15 m | $64.84M |
| 51 | W1761 | $63.39M | |
| 52 | 92508 | Group treatment of speech, language, voice, communication, and/or auditory processing disorder | $62.94M |
| 53 | 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | $61.63M |
| 54 | 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | $61.54M |
| 55 | 99309 | Subsequent nursing facility care, per day, low to moderate complexity | $60.99M |
| 56 | H0032 | Mental health service plan development by non-physician | $60.77M |
| 57 | 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | $59.82M |
| 58 | 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | $59.49M |
| 59 | 81415 | $59.35M | |
| 60 | G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | $58.39M |
| 61 | U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | $57.37M |
| 62 | 90853 | Group psychotherapy (other than of a multiple-family group) | $56.83M |
| 63 | T1016 | Case management, each 15 minutes | $56.35M |
| 64 | D2391 | Resin-based composite - one surface, posterior, primary or permanent | $54.47M |
| 65 | 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | $51.63M |
| 66 | D8670 | Periodic orthodontic treatment visit | $51.29M |
| 67 | H0001 | Alcohol and/or drug assessment | $51.28M |
| 68 | 99283 | Emergency department visit for the evaluation and management, moderate severity | $50.79M |
| 69 | D2930 | Prefabricated stainless steel crown - primary tooth | $50.67M |
| 70 | 41899 | Unlisted procedure, dentoalveolar structures | $48.93M |
| 71 | 90792 | Psychiatric diagnostic evaluation with medical services | $47.23M |
| 72 | 99308 | Subsequent nursing facility care, per day, straightforward | $46.49M |
| 73 | 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | $43.37M |
| 74 | H0025 | Behavioral health prevention education service (delivery of services with target population to affect knowledge, attitude and/or behavior) | $43.26M |
| 75 | G9003 | Coordinated care fee, risk adjusted high, initial | $41.28M |
| 76 | 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | $40.61M |
| 77 | D0150 | Comprehensive oral evaluation - new or established patient | $39.02M |
| 78 | D7140 | Extraction, erupted tooth or exposed root | $36.73M |
| 79 | H0036 | Community psychiatric supportive treatment, face-to-face, per 15 minutes | $36.30M |
| 80 | G0378 | Hospital observation service, per hour | $36.29M |
| 81 | G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | $35.56M |
| 82 | S5135 | Companion care, adult (e.g., iadl/adl); per 15 minutes | $34.99M |
| 83 | 90999 | Unlisted dialysis procedure, inpatient or outpatient | $34.81M |
| 84 | G0299 | Direct skilled nursing services of a registered nurse (rn) in the home health or hospice setting, each 15 minutes | $34.45M |
| 85 | T4527 | Adult sized disposable incontinence product, protective underwear/pull-on, large size, each | $33.04M |
| 86 | H0031 | Mental health assessment, by non-physician | $32.15M |
| 87 | T4535 | Disposable liner/shield/guard/pad/undergarment, for incontinence, each | $31.88M |
| 88 | T4526 | Adult sized disposable incontinence product, protective underwear/pull-on, medium size, each | $31.21M |
| 89 | A0425 | Ground mileage, per statute mile | $30.90M |
| 90 | 97153 | Adaptive behavior treatment by protocol, administered by technician, each 15 minutes | $30.43M |
| 91 | D2393 | Resin-based composite - three surfaces, posterior, primary or permanent | $29.95M |
| 92 | D1208 | Topical application of fluoride, excluding varnish | $29.17M |
| 93 | J0574 | Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine | $27.22M |
| 94 | G9004 | Coordinated care fee, risk adjusted low, initial | $26.75M |
| 95 | S9124 | Nursing care, in the home; by licensed practical nurse, per hour | $26.23M |
| 96 | S9088 | Services provided in an urgent care center (list in addition to code for service) | $26.15M |
| 97 | D0330 | Panoramic radiographic image | $26.02M |
| 98 | 99223 | Prolong inpt eval add15 m | $25.54M |
| 99 | D8080 | Comprehensive orthodontic treatment of the adolescent dentition | $25.47M |
| 100 | 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | $25.26M |
| 101 | D7240 | Removal of impacted tooth - completely bony | $25.06M |
| 102 | 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | $25.06M |
| 103 | 77067 | Screening mammography, bilateral, including computer-aided detection | $24.79M |
| 104 | T2021 | Day habilitation, waiver; per 15 minutes | $24.09M |
| 105 | G0151 | Services performed by a qualified physical therapist in the home health or hospice setting, each 15 minutes | $24.04M |
| 106 | E1390 | Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate | $23.60M |
| 107 | B4035 | Enteral feeding supply kit; pump fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape | $23.39M |
| 108 | H0047 | Alcohol and/or other drug abuse services, not otherwise specified | $23.27M |
| 109 | 88305 | Level IV - Surgical pathology, gross and microscopic examination | $22.93M |
| 110 | D0140 | Limited oral evaluation - problem focused | $22.33M |
| 111 | D0274 | Bitewings - four radiographic images | $21.99M |
| 112 | 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | $21.86M |
| 113 | T4541 | Incontinence product, disposable underpad, large, each | $21.45M |
| 114 | 99205 | Prolong outpt/office vis | $21.07M |
| 115 | D3330 | Endodontic therapy, molar tooth (excluding final restoration) | $20.89M |
| 116 | T2033 | Residential care, not otherwise specified (nos), waiver; per diem | $20.61M |
| 117 | 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | $20.48M |
| 118 | R0070 | Transportation of portable x-ray equipment and personnel to home or nursing home, per trip to facility or location, one patient seen | $20.41M |
| 119 | A6250 | Skin sealants, protectants, moisturizers, ointments, any type, any size | $20.29M |
| 120 | D0272 | Bitewings - two radiographic images | $19.32M |
| 121 | A4927 | Gloves, non-sterile, per 100 | $18.82M |
| 122 | 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | $17.75M |
| 123 | 90846 | Family psychotherapy without the patient present, 50 minutes | $17.56M |
| 124 | T4528 | Adult sized disposable incontinence product, protective underwear/pull-on, extra large size, each | $17.48M |
| 125 | 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | $17.47M |
| 126 | 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | $17.36M |
| 127 | 96159 | $17.10M | |
| 128 | 74177 | Computed tomography, abdomen and pelvis; with contrast material | $16.71M |
| 129 | W7310 | $16.60M | |
| 130 | 81229 | $16.50M | |
| 131 | 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | $16.47M |
| 132 | 90670 | $16.15M | |
| 133 | T2003 | Non-emergency transportation; encounter/trip | $15.91M |
| 134 | 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | $15.72M |
| 135 | 90836 | $15.17M | |
| 136 | B4161 | Enteral formula, for pediatrics, hydrolyzed/amino acids and peptide chain proteins, includes fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit | $14.87M |
| 137 | J0178 | Injection, aflibercept, 1 mg | $14.83M |
| 138 | 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | $14.22M |
| 139 | 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | $14.17M |
| 140 | W0038 | $13.78M | |
| 141 | 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | $13.73M |
| 142 | H2014 | Skills training and development, per 15 minutes | $13.58M |
| 143 | W9323 | $13.46M | |
| 144 | 90686 | $13.14M | |
| 145 | A4554 | Disposable underpads, all sizes | $13.04M |
| 146 | 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | $13.03M |
| 147 | V2020 | Frames, purchases | $12.74M |
| 148 | J2357 | Injection, omalizumab, 5 mg | $12.64M |
| 149 | Q5104 | Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | $12.56M |
| 150 | H2022 | Community-based wrap-around services, per diem | $12.56M |
| 151 | T2025 | Waiver services; not otherwise specified (nos) | $12.54M |
| 152 | D2750 | $12.47M | |
| 153 | A9276 | Sensor; invasive (e.g., subcutaneous), disposable, for use with non-durable medical equipment interstitial continuous glucose monitoring system, one unit = 1 day supply | $12.37M |
| 154 | 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | $12.02M |
| 155 | S9123 | Nursing care, in the home; by registered nurse, per hour (use for general nursing care only, not to be used when cpt codes 99500-99602 can be used) | $11.61M |
| 156 | 97155 | Adaptive behavior treatment with protocol modification, administered by physician, each 15 minutes | $11.54M |
| 157 | D0220 | Intraoral - periapical first radiographic image | $11.45M |
| 158 | 81420 | Fetal chromosomal aneuploidy genomic sequence analysis panel | $11.29M |
| 159 | D9230 | Inhalation of nitrous oxide / analgesia, anxiolysis | $11.29M |
| 160 | 99239 | Hospital discharge day management, more than 30 minutes | $11.16M |
| 161 | 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | $11.08M |
| 162 | H0016 | Alcohol and/or drug services; medical/somatic (medical intervention in ambulatory setting) | $10.86M |
| 163 | 70450 | Computed tomography, head or brain; without contrast material | $10.86M |
| 164 | D8660 | $10.74M | |
| 165 | S0201 | Partial hospitalization services, less than 24 hours, per diem | $10.72M |
| 166 | 71046 | Radiologic examination, chest; 2 views | $10.50M |
| 167 | E0465 | Home ventilator, any type, used with invasive interface, (e.g., tracheostomy tube) | $10.34M |
| 168 | D9223 | Deep sedation/general anesthesia - each subsequent 15 minute increment | $9.87M |
| 169 | 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | $9.83M |
| 170 | 99281 | Emergency department visit for the evaluation and management, self-limited or minor | $9.82M |
| 171 | J1559 | Injection, immune globulin (hizentra), 100 mg | $9.71M |
| 172 | T4523 | Adult sized disposable incontinence product, brief/diaper, large, each | $9.43M |
| 173 | 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | $9.30M |
| 174 | 36415 | Collection of venous blood by venipuncture | $9.26M |
| 175 | G0463 | Hospital outpatient clinic visit for assessment and management of a patient | $9.17M |
| 176 | 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | $9.13M |
| 177 | 99222 | Initial hospital care, per day, moderate complexity | $9.08M |
| 178 | E0601 | Continuous positive airway pressure (cpap) device | $9.02M |
| 179 | D8090 | $8.86M | |
| 180 | G0152 | Services performed by a qualified occupational therapist in the home health or hospice setting, each 15 minutes | $8.81M |
| 181 | 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | $8.71M |
| 182 | 80053 | Comprehensive metabolic panel | $8.63M |
| 183 | A5120 | Skin barrier, wipes or swabs, each | $8.60M |
| 184 | U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | $8.57M |
| 185 | 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | $8.47M |
| 186 | T4524 | Adult sized disposable incontinence product, brief/diaper, extra large, each | $8.36M |
| 187 | 71045 | Radiologic examination, chest; single view | $8.35M |
| 188 | S9480 | Intensive outpatient psychiatric services, per diem | $8.31M |
| 189 | 93000 | $8.26M | |
| 190 | 76830 | Ultrasound, transvaginal | $8.23M |
| 191 | S1040 | Cranial remolding orthosis, pediatric, rigid, with soft interface material, custom fabricated, includes fitting and adjustment(s) | $8.15M |
| 192 | A4624 | Tracheal suction catheter, any type other than closed system, each | $8.07M |
| 193 | 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | $8.06M |
| 194 | W9306 | $7.99M | |
| 195 | J0572 | Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine | $7.99M |
| 196 | 80061 | Lipid panel | $7.96M |
| 197 | 76819 | Fetal biophysical profile; without non-stress testing | $7.80M |
| 198 | 99469 | Subsequent inpatient neonatal critical care, per day, 28 days or younger | $7.71M |
| 199 | S9131 | Physical therapy; in the home, per diem | $7.65M |
| 200 | 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | $7.64M |